-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Liver cancer is the sixth most common cancer in the world and the third leading cause of cancer-related deaths worldwide
Liver cancer is the sixth most common cancer in the world and the third leading cause of cancer-related deaths worldwide
More and more evidences show that HCC and embryonic liver development share many common molecular characteristics
In this study, the researchers studied the expression levels and clinical relevance of SLC38A4 and HMGCS2 through qRT-PCR, Western blot, TCGA and GEO data sets, and studied the biological effects of SLC38A4 through functional assays
Compared with adults, the expression of Slc38a4 in fetal liver is down-regulated
Compared with adults, the expression of Slc38a4 in fetal liver is down-regulatedFunctional studies have shown that knocking out SLC38A4 can promote the proliferation, stem cell characteristics and migration ability of HCC cells, inhibit the apoptosis of HCC cells in vitro, and further inhibit the occurrence of HCC tumors in vivo
stem cell
The expression of SLC38A4 is down-regulated in HCC tissues and is negatively correlated with the prognosis of patients
The expression of SLC38A4 is down-regulated in HCC tissues and is negatively correlated with the prognosis of patientsAll in all, the results of the study showed that down-regulation of SLC38A4 expression is considered a new carcinoembryonic event, and SLC38A4 has also been identified as a new tumor suppressor in the development of HCC
The down-regulation of SLC38A4 expression is considered to be a new carcinoembryonic event, and SLC38A4 has also been identified as a new tumor suppressor in the occurrence and development of HCC
SLC38A4 functions as a tumour suppressor in hepatocellular carcinoma through modulating Wnt/β-catenin/MYC/HMGCS2 axis.
Leave a message here